Redpoint Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-69,260
Closed -$6.88M 620
2019
Q3
$6.88M Buy
69,260
+7,326
+12% +$696K 0.36% 59
2019
Q2
$5.72M Sell
61,934
-2,374
-4% -$225K 0.3% 75
2019
Q1
$6.07M Sell
64,308
-9,159
-12% -$801K 0.3% 77
2018
Q4
$4.71M Buy
73,467
+18,144
+33% +$1.34M 0.27% 83
2018
Q3
$4.95M Hold
55,323
0.25% 100
2018
Q2
$4.39M Hold
55,323
0.24% 106
2018
Q1
$4.93M Buy
55,323
+1,125
+2% +$108K 0.27% 93
2017
Q4
$5.66M Buy
+54,198
New +$6.12M 0.31% 73

Other funds holding CELG

Redpoint Investment Management's CELG Position: Q4 2019 in Review

Redpoint Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 69,260 shares — an estimated $6.88M sold.

Redpoint Investment Management first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $6.88M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Redpoint Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Redpoint Investment Management sold 69,260 Celgene Corp shares in Q4 2019, an estimated $6.88M.
  • Redpoint Investment Management first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • Redpoint Investment Management's Celgene Corp position peaked at $6.88M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Redpoint Investment Management's 13F filing for Q4 2019, filed 25 Feb 2020.